Greystone Research Associates - Latest News [Page 1]
Developers Seek to Deliver Drugs in High Doses Subcutaneously
Tuesday, 10 May 2016, 10:26 am | Greystone Research Associates
(Amherst, NH) – As the trend favoring biological drugs as a percent of all drugs continues, the number of injectables that exceed 1 mL per dose, the de facto limit for comfortable and safe patient self-administration, is also increasing. Drugs that ... More >>
Drug Developers and Marketers Re-tool their Strategies
Tuesday, 2 June 2015, 3:30 pm | Greystone Research Associates
Biosimilars and New NCEs Threaten Incumbent Products from Two Sides According to Greystone Research Associates More >>
Closed Systems for Handling Cytotoxic Drugs Acceptance
Tuesday, 8 January 2013, 10:17 am | Greystone Research Associates
(Amherst, NH) – Paralleling the regulatory and standards-based trend that has driven the safety syringe market, caregivers in growing numbers are joining the ongoing dialogue about the benefits and issues related to the use of closed transfer systems ... More >>